13D/13G Filings - Cormorant Asset Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
3:04 pm
Sale
2021-12-31 13G Otonomy, Inc.
OTIC
Cormorant Asset Management LP 0
0.000%
-2,600,000decrease
(Position Closed)
Filing
2022-02-14
3:03 pm
Sale
2021-12-31 13G Omeros Corporation
OMER
Cormorant Asset Management LP 0
0.000%
-5,000,000decrease
(Position Closed)
Filing
History
2022-02-14
3:02 pm
Purchase
2021-12-31 13G Turning Point Therapeutics, Inc.
TPTX
Cormorant Asset Management LP 3,025,000
6.110%
632,703increase
(+26.45%)
Filing
History
2022-02-14
3:01 pm
Sale
2021-12-31 13G Olema Pharmaceuticals, Inc.
OLMA
Cormorant Asset Management LP 2,169,871
5.390%
-1,025,673decrease
(-32.10%)
Filing
History
2022-02-14
3:01 pm
Sale
2021-12-31 13G Tarsus Pharmaceuticals, Inc.
TARS
Cormorant Asset Management LP 1,403,331
6.790%
-310,938decrease
(-18.14%)
Filing
History
2022-02-14
3:00 pm
Purchase
2021-12-31 13G Eledon Pharmaceuticals, Inc.
ELDN
Cormorant Asset Management LP 1,428,598
9.900%
1,428,598increase
(New Position)
Filing
History
2021-08-13
4:01 pm
Purchase
2021-08-03 13G Immuneering Corporation
IMRX
Cormorant Asset Management LP 2,252,628
8.830%
2,252,628increase
(New Position)
Filing
History
2021-08-10
4:01 pm
Unchanged
2021-07-26 13D Erasca, Inc.
ERAS
Cormorant Asset Management LP 10,505,553
8.830%
0
(Unchanged)
Filing
History
2021-07-30
4:01 pm
Purchase
2021-07-20 13D Erasca, Inc.
ERAS
Cormorant Asset Management LP 10,505,553
8.830%
10,505,553increase
(New Position)
Filing
History
2021-07-12
4:19 pm
Purchase
2021-07-02 13G Aerovate Therapeutics, Inc.
AVTE
Cormorant Asset Management LP 2,030,691
8.320%
2,030,691increase
(New Position)
Filing
History
2021-07-09
4:06 pm
Purchase
2021-06-29 13G Elevation Oncology, Inc.
ELEV
Cormorant Asset Management LP 1,983,168
8.690%
1,983,168increase
(New Position)
Filing
History
2021-07-08
4:02 pm
Purchase
2021-06-28 13G Monte Rosa Therapeutics, Inc.
GLUE
Cormorant Asset Management LP 3,193,974
7.180%
3,193,974increase
(New Position)
Filing
History
2021-07-02
4:12 pm
Purchase
2021-06-22 13G Ambrx Biopharma Inc.
AMAM
Cormorant Asset Management LP 17,404,702
6.600%
17,404,702increase
(New Position)
Filing
History
2021-05-19
4:09 pm
Purchase
2021-05-18 13G Revolution Medicines, Inc.
RVMD
Cormorant Asset Management LP 3,675,000
5.000%
1,179,934increase
(+47.29%)
Filing
History
2021-04-09
4:07 pm
Purchase
2021-03-30 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,114,844
9.200%
5,114,844increase
(New Position)
Filing
History
2021-03-26
4:06 pm
Purchase
2021-03-16 13G Prometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP 2,098,022
5.410%
2,098,022increase
(New Position)
Filing
2021-03-26
4:05 pm
Purchase
2021-03-16 13G Longboard Pharmaceuticals, Inc.
LBPH
Cormorant Asset Management LP 1,339,631
9.990%
1,339,631increase
(New Position)
Filing
History
2021-02-16
3:34 pm
Sale
2020-12-31 13G Tarsus Pharmaceuticals, Inc.
TARS
Cormorant Asset Management LP 1,714,269
8.450%
-249,999decrease
(-12.73%)
Filing
History
2021-02-16
3:33 pm
Sale
2020-12-31 13G Atea Pharmaceuticals, Inc.
AVIR
Cormorant Asset Management LP 6,411,355
7.760%
-475,000decrease
(-6.90%)
Filing
History
2021-02-16
3:32 pm
Sale
2020-12-31 13G Galecto, Inc.
GLTO
Cormorant Asset Management LP 86,029
8.510%
-5,220decrease
(-5.72%)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next